Viewing Study NCT07286266

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:24 PM
Ignite Modification Date: 2026-02-02 @ 3:45 PM
Study NCT ID: NCT07286266
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2025-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Platinum-resistant Ovarian Cancer View
None GSK5733584 View
None Paclitaxel View
None Pegylated liposomal doxorubicin (PLD) View
None Topotecan View
None Gemcitabine View
None Antibody-drug conjugate View
None BEHOLD-Ovarian01 View